Standard Lithium (NYSE:SLI) vs. BioLargo (NASDAQ:BLGO) Head to Head Survey

BioLargo (NASDAQ:BLGO) and Standard Lithium (NYSE:SLI) are both small-cap construction companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, earnings, valuation, risk, profitability and dividends.

Valuation and Earnings

This table compares BioLargo and Standard Lithium”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioLargo	$12.23 million	7.08	-$3.50 million	($0.01)	-28.76
Standard Lithium	N/A	N/A	$108.82 million	$0.59	2.85

Standard Lithium has lower revenue, but higher earnings than BioLargo. BioLargo is trading at a lower price-to-earnings ratio than Standard Lithium, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

BioLargo has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, Standard Lithium has a beta of 1.67, indicating that its share price is 67% more volatile than the S&P 500.

Profitability

This table compares BioLargo and Standard Lithium’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioLargo	-11.45%	-39.90%	-22.06%
Standard Lithium	N/A	-11.52%	-10.25%

Analyst Ratings

This is a breakdown of recent ratings and target prices for BioLargo and Standard Lithium, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioLargo	0	0	0	0	0.00
Standard Lithium	0	0	2	0	3.00

Standard Lithium has a consensus price target of $3.95, indicating a potential upside of 135.12%. Given Standard Lithium’s stronger consensus rating and higher probable upside, analysts plainly believe Standard Lithium is more favorable than BioLargo.

Insider and Institutional Ownership

0.0% of BioLargo shares are held by institutional investors. Comparatively, 16.8% of Standard Lithium shares are held by institutional investors. 20.3% of BioLargo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Standard Lithium beats BioLargo on 11 of the 13 factors compared between the two stocks.

About BioLargo

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

About Standard Lithium

Standard Lithium Ltd. explores for, develops, and processes lithium brine properties in the United States. Its flagship project is the Lanxess project with area of approximately 150,000 acres located in southern Arkansas. The company was formerly known as Patriot Petroleum Corp. and changed its name to Standard Lithium Ltd. in December 2016. Standard Lithium Ltd. was incorporated in 1998 and is headquartered in Vancouver, Canada.